Literature DB >> 19494515

Role of IL-23-Th17 cell axis in allergic airway inflammation.

Hidefumi Wakashin1, Koichi Hirose, Itsuo Iwamoto, Hiroshi Nakajima.   

Abstract

Asthma is characterized by chronic airway inflammation with intense eosinophil and lymphocyte infiltration, mucus hyperproduction, and airway hyperresponsiveness to a variety of stimuli. It is now generally accepted that antigen-specific Th2 cells and their cytokines orchestrate these pathognomonic features of asthma. On the other hand, Th17 cells and IL-23, a cytokine that preferentially expands Th17 cells, play a significant role in the development of chronic inflammatory diseases, including autoimmune diseases. Recently, we have shown that IL-23 and Th17 cells enhance not only neutrophilic airway inflammation but also Th2 cell-mediated eosinophilic airway inflammation in a murine asthma model. In this review, we will discuss the roles of IL-23 and Th17 cells in airway inflammation in asthma. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19494515     DOI: 10.1159/000211382

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  19 in total

Review 1.  Plasticity of T-cell phenotype and function: the T helper type 17 example.

Authors:  Ariana Peck; Elizabeth D Mellins
Journal:  Immunology       Date:  2009-11-17       Impact factor: 7.397

2.  Interleukin-33 ameliorates experimental colitis through promoting Th2/Foxp3⁺ regulatory T-cell responses in mice.

Authors:  Lihua Duan; Jie Chen; Hongwei Zhang; Heng Yang; Ping Zhu; Ali Xiong; Quansong Xia; Fang Zheng; Zheng Tan; Feili Gong; Min Fang
Journal:  Mol Med       Date:  2012-07-18       Impact factor: 6.354

3.  IL-17E (IL-25) and IL-17RB promote respiratory syncytial virus-induced pulmonary disease.

Authors:  Bryan C Petersen; Vladislav Dolgachev; Andrew Rasky; Nicholas W Lukacs
Journal:  J Leukoc Biol       Date:  2014-01-09       Impact factor: 4.962

Review 4.  Unexpected targets and triggers of autoimmunity.

Authors:  Youjin Lee; Mary Collins; Vijay K Kuchroo
Journal:  J Clin Immunol       Date:  2014-05-01       Impact factor: 8.317

5.  A role for T-bet-mediated tumour immune surveillance in anti-IL-17A treatment of lung cancer.

Authors:  S Reppert; I Boross; M Koslowski; Ö Türeci; S Koch; H A Lehr; S Finotto
Journal:  Nat Commun       Date:  2011-12-20       Impact factor: 14.919

6.  Association of the miR-196a2, miR-146a, and miR-499 Polymorphisms with Asthma Phenotypes in a Korean Population.

Authors:  Hoang Kim Tu Trinh; Duy Le Pham; Su-Chin Kim; Ri-Yeon Kim; Hae-Sim Park; Seung-Hyun Kim
Journal:  Mol Diagn Ther       Date:  2017-10       Impact factor: 4.074

7.  IL-33 Enhances Humoral Immunity Against Chronic HBV Infection Through Activating CD4(+)CXCR5(+) TFH Cells.

Authors:  Ping-Wei Zhao; Xu Shi; Cong Li; Desalegn Admassu Ayana; Jun-Qi Niu; Jun-Yan Feng; Juan Wang; Yan-Fang Jiang
Journal:  J Interferon Cytokine Res       Date:  2015-02-25       Impact factor: 2.607

Review 8.  Interleukin-17 regulation: an attractive therapeutic approach for asthma.

Authors:  Seoung Ju Park; Yong Chul Lee
Journal:  Respir Res       Date:  2010-06-16

9.  Th17 cells demonstrate stable cytokine production in a proallergic environment.

Authors:  Nicole L Glosson-Byers; Sarita Sehra; Gretta L Stritesky; Qing Yu; Olufolakemi Awe; Duy Pham; Heather A Bruns; Mark H Kaplan
Journal:  J Immunol       Date:  2014-08-01       Impact factor: 5.422

Review 10.  Pentraxin 3(PTX 3): an endogenous modulator of the inflammatory response.

Authors:  P Kunes; Z Holubcova; M Kolackova; J Krejsek
Journal:  Mediators Inflamm       Date:  2012-04-11       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.